This content is from: Patents

Eli Lilly counsel reflects on twists and turns of Alimta lawsuits

Ivan Burnside tells Managing IP how the pemetrexed case on salt substitution shook up European patent law

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial